These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 22991406)

  • 1. Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions.
    Mitar M; Alba AC; MacIver J; Ross H
    Circ Heart Fail; 2012 Sep; 5(5):660-6. PubMed ID: 22991406
    [No Abstract]   [Full Text] [Related]  

  • 2. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with ICDs at the end of life (EOL): a qualitative study.
    Kelley AS; Mehta SS; Reid MC
    Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing with pacemakers and implantable cardioverter defibrillators.
    Lampert R
    Circulation; 2013 Oct; 128(14):1576-85. PubMed ID: 24081953
    [No Abstract]   [Full Text] [Related]  

  • 5. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
    Waterhouse E; Ahmad F
    Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know.
    Sears SF; Hauf JD; Kirian K; Hazelton G; Conti JB
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):242-50. PubMed ID: 21505176
    [No Abstract]   [Full Text] [Related]  

  • 7. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
    Francia P; Cappato R
    G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
    [No Abstract]   [Full Text] [Related]  

  • 8. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
    Daeschler M; Verdino RJ; Kirkpatrick JN
    Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical issues on defibrillator deactivation in end-of-life patients.
    Facciorusso A; Stanislao M; Fanelli M; Valori VM; Valle G
    J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):498-500. PubMed ID: 21610508
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving Communication in Heart Failure Patient Care.
    Goldstein NE; Mather H; McKendrick K; Gelfman LP; Hutchinson MD; Lampert R; Lipman HI; Matlock DD; Strand JJ; Swetz KM; Kalman J; Kutner JS; Pinney S; Morrison RS
    J Am Coll Cardiol; 2019 Oct; 74(13):1682-1692. PubMed ID: 31558252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual case of impossible communication between an ICD and programmer.
    Attanasio P; Wutzler A; Huemer M; Parwani AS; Boldt LH; Haverkamp W; Blaschke F
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):230. PubMed ID: 25257919
    [No Abstract]   [Full Text] [Related]  

  • 13. [Deactivation of implantable defibrillators--also an ethical issue. Written routines of the process are necessary as illustrated by the described case report].
    Carlsson J; Mansson A; Olsson D
    Lakartidningen; 2011 Mar 9-15; 108(10):536-9. PubMed ID: 21744554
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective communication and ethical consent in decisions related to ICDs.
    Clark AM; Jaarsma T; Strachan P; Davidson PM; Jerke M; Beattie JM; Duncan AS; Ski CF; Thompson DR
    Nat Rev Cardiol; 2011 Jul; 8(12):694-705. PubMed ID: 21788961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared Decision-Making About End-of-Life Care Scenarios Compared Among Implantable Cardioverter Defibrillator Patients: A National Cohort Study.
    Thompson JH; Thylén I; Moser DK
    Circ Heart Fail; 2019 Oct; 12(10):e005619. PubMed ID: 31601115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 18. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.
    Palacios-Ceña D; Losa-Iglesias ME; Alvarez-López C; Cachón-Pérez M; Reyes RA; Salvadores-Fuentes P; Fernández-de-Las-Peñas C
    J Adv Nurs; 2011 Dec; 67(12):2537-50. PubMed ID: 21615459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magical thinking around end of life: An editorial on 'Implantable Cardioverter Defibrillator deactivation discussions: Reality vs. recommendations'.
    MacKenzie MA
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):8-9. PubMed ID: 26791007
    [No Abstract]   [Full Text] [Related]  

  • 20. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
    Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
    G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.